Skip to main content

Advertisement

Log in

Vivo para consumirla y la consumo para vivir” [“I live to inject and inject to live”]: High-Risk Injection Behaviors in Tijuana, Mexico

  • Original Articles: Various Topics
  • Published:
Journal of Urban Health Aims and scope Submit manuscript

Abstract

Injection drug use is a growing problem on the US-mexico border, where Tijuana is situated. We studied the context of injection drug use among injection drug users (IDUs) in Tijuana to help guide future research and interventions. Guided indepth interviews were conducted with 10 male and 10 female current IDUs in Tijuana. Topics included types of drug used, injection settings, access to sterile needles, and environmental influences. Interviews were taped, transcribed verbatim, and translated. Content analysis was conducted to identify themes. Of the 20 IDUs, median age and age at first injection were 30 and 18. Most reported injecting at least daily: heroin (“carga,” “chiva”, “negra”), methamphetamine (“crico,” “cri-cri”), or both drugs combined. In sharp contrast to Western US cities, almost all regularly attended shooting galleries (“yongos” or “picaderos”) because of the difficulties obtaining syringes and police oppression. Almost all shared needles/paraphernalia [“cuete” (syringe), “cacharros” (cookers), cotton from sweaters/socks (filters)]. Some reported obtaining syringes from the United States. Key themes included (1) pharmacies refusing to sell or charging higher prices to IDUs, (2) ample availability of used/rented syringes from “picaderos” (e.g., charging approximately 5 pesos or “10 drops” of drug), and (3) poor HIV/AIDS knowledge, such as beliefs that exposing syringes to air “kills germs.” This qualitative study suggests that IDUs in Tijuana are at high risk of HIV and other blood-borne infections. Interventions are urgently needed to expand access to sterile injection equipment and offset the potential for a widespread HIV epidemic.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. INEGI (Instituto Nacional de Estadistica, Geografia e Informatica). Preliminary Results for the XII National Population and Housing Census-2000. (Resultados Preliminares del XII Censo Nacional de Población y Vivienda 2000). México, Distrito Federal, 2000.

  2. COPLADEM (Comité de Planeación para el Desarrollo del Estado de México) Plan Municipal de Desarrollo 1996–1998, Tijuana. SDSU Institute for Regional Studies of the Californias. Available at: http://www-rohan.sdsu.edu/≈irsc/tjreport/tj9.html. Accessed April 15, 2005.

  3. SDSU Institute for Regional Studies of the Californias. Available at: http:/www-rohan.sdsu.edu/≈irsc/tjreport/tj3.html. Accessed April 15, 2005.

  4. Lange JE, Lauer EM, Voas RB. A survey of the San Diego-Tijuana cross-border binding. Eval Rev. 1999;23:378–398.

    Article  CAS  PubMed  Google Scholar 

  5. Huntington SP. The Hispanic challenge. Foreign Policy [serial online]. Available at: http://www.foreignpolicy.com/story/cms.php?story_id=2495. Accessed June 30, 2004.

  6. Central Intelligence Agency. The world factbook. Available at: http://www.cia.gov/cia/publications/factbook/. Accessed March 10, 2005.

  7. Drug Enforcement Administration. Mexico: country profile for 2003. drug Intelligence Report DEA-03047. Available at: http://www.usdoj.gov/dea/pubs/intel/03047/03047.pdf. Accessed July 12, 2004.

  8. Beyrer C, Razak MH, Lisam K, Chen J, Lui W, Yu XF. Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS. 2000;14:75–83.

    Article  CAS  PubMed  Google Scholar 

  9. Adelekan ML, Stimson GV. Problems and prospects of implementing harm reduction for HIV and injecting drug use in high risk sub-Saharan African countries. J Drug Issues. 1997;27:97–116.

    Google Scholar 

  10. Bastos FI, Strathdee SA, Derrico M, Pina MDF. Drug abuse and the spread of HIV/AIDS in South America and the Caribbean. Drugs Educ Prev Policy. 1999;6:29–50.

    Article  Google Scholar 

  11. Bucardo J, Brouwer KC, Magis C, et al. Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood borne infections. Drug and Alcohol Dependence. In press.

  12. Magis-Rodriguez C, Ruiz-Badillo A, Oritiz-Mondragon R, Loya-Sepulveda M, Bravo-Portela MJ, Lozada R. Estudio sobre prácticas de riesgo de infección para VIH/SIDA en inyectores de drogas de la cd. de Tijuana B.C. Biblioteca Virtual en Salud [serial online]. 2002. Available at: http://bvs.insp.mx/componen/svirtual/ppriori/09/0399/arti.htm. Accessed July 25, 2004.

  13. Secretaria de Salud, consejo Nacional Contra las Adicciones (SSA-CONADIC). Encuesta Nacional de Adicciones 1999. Available at: http://www.salud.gob.mx/unidades/conadic/epidem.htm. Accessed February 14, 2004.

  14. Morales S, Lozada R, Magis C, Saavedra JA, Monitoreo. Evaluation of HIV prevention interventions in injectable drug users in Mexico. In: XV international Conference on AIDS; July 11–17, 2004; Bangkok, Thailand.

  15. UNAIDS. Report on the Global HIV/AIDS Epidemic, 2002. July 2002; Geneva, Switzerland.

  16. CONASIDA. Panorama Epidemiológico del VIH/SIDA e ITS en México [Epidemiologic overview of HIV/AIDS and STD in México]. Available at: http://www.salud.gob.mx/conasida/comite/minutas/cua20020.pdf. Accessed October 29, 2002.

  17. Magis-Rodríguez C, Bravo-García E, Rivera Reyes P. El sida en México en el año 2000. In: Uribe, P, Magis, C, eds La Respuesta Mexicana Al SIDA: Mejores Prácticas. México: Ángulos Del SIDA. Mexico, Distrito Federal: Consejo Nacional para la Prevencion y Control del SIDA; 2000:13–22.

    Google Scholar 

  18. Viani RM, Hubbard P, Araneta MR, et al. Pregnant women in Baja California, Mexico: evidence of an emerging crisis? XV International Conference on AIDS; July 11–17, 2004; Bangkok, thailand.

  19. Magis C, Brower KC, Morales S, et al. Correlates of receptive needle sharing among injection drug users (IDUs) in the US-Mexican border city of Tijuana. In:3rd International Conference on Urban Health; October 20–22, 2004; Boston, MA.

  20. Normand J, Vlahov D, Moses LE. Preventing HIV Transmission: The Role of Sterile Needles and Bleach. Washington, DC: National Academy Press; 1995.

    Google Scholar 

  21. Bastos FI, Strathdee SA. Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. Soc Sci Med. 2000;51:1771–1782.

    Article  CAS  PubMed  Google Scholar 

  22. Des J, Hagan H, Friedman SR, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA. 1995;274:1226–1231.

    Article  Google Scholar 

  23. Emerson R. Producing ethnographies: theory, evidence and representation. In: Emerson R, ed. Contemporary Field Research. Prospect Heights, IL, Waveland Press; 2001:295–296.

    Google Scholar 

  24. Watters JK, Biernacki P. Targeted sampling. options for the study of hidden populations. Soc Probl. 1989;36:416–430.

    Google Scholar 

  25. Greenfield L, Bigelow GE, Brooner RK. HIV risk behavior in drug users: increased blood “booting” during cocaine injections. AIDS Educ Prev. 1992;4:95–107.

    CAS  PubMed  Google Scholar 

  26. Bruneau J, Lamothe F, Franco E, et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol. 1997;146:994–1002.

    CAS  PubMed  Google Scholar 

  27. Rhodes T, Mikhailova LA, Sarang A, et al. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliati City, Russian Federation: a qualitative study of miero risk environment. Soc Sci Med. 2003;57:39–54.

    Article  PubMed  Google Scholar 

  28. Burris S, Lurie P, Abrahamson D, Rich JD. Physician prescribing of sterile injection equipment to prevent HIV infection: time for action. Ann Intern Med. 2000;133:218–226.

    CAS  PubMed  Google Scholar 

  29. Case PL, Meehan T, Jones TS. Arrests and incarceration of injection drug users for syringe possesion in Massachusetts: implications for HIv prevention. J Acquir Immune Defic Syndr. 1998;18:S71-S75.

    Google Scholar 

  30. Case PL, Beckett GA, Jones TS. Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law. J Acquir Immune Defic Syndr. 1998;18:S94-S101.

    Google Scholar 

  31. Taussig JA, Weinstein B, Burris S, Jones TS. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. AIDS. 2000;14:S47-S51.

    Article  PubMed  Google Scholar 

  32. Reich W, Compton WM, Horton JC, et al. Pharmacist ambivalence about sale of syringes to injection drug users. J Am Pharm Assoc (Wash). 2002;42:S52-S57.

    Google Scholar 

  33. Celentano D, Vlahov D, Cohn S, Anthony JC, Solomon L, Nelson KE. Risk factors for shooting gallery use and cessation among intravenous drug users. Am J Public Health. 1991;81:1291–1295.

    Article  CAS  PubMed  Google Scholar 

  34. Page JB, Smith PC, Kane N. Shooting galleries, their proprietors, and implications for prevention of AIDS. Drugs Soc. 1990;5:69–85.

    Google Scholar 

  35. Robles RR, Marrero CA, Reyes JC, et al. Risk behavior, HIV seropositivity, and tuberculosis infection in injecting drug users who operate shooting galleries in Puerto Rico. J Acquir Immune Defic Syndr. 1998;17:477–483.

    CAS  Google Scholar 

  36. Garfein RS, Monterroso E, Tong TC, et al. Comparisson of HIV infection risk behaviors among injection drug users from east and west coast US cities. J Urban Health. 2004;81:260–267.

    PubMed  Google Scholar 

  37. Burris S, Blankenship KM, Donoghoe M, et al. Addressing the “risk environment” for injection drug users: the mysterious case of the missing cop. Milbank Q. 2004;82:125–156.

    Article  PubMed  Google Scholar 

  38. Koester S. Copping, running and paraphernalia laws: contextual and needle risk behaviors among drug users in Denver. Human Organ. 1994;53:287–295.

    Google Scholar 

  39. Strathdee SA, Zafar T, Brahmbhatt H, Baksh A, ul Hassan S. Rise in needle sharing among injection drug users in Pakistan during the Afghanistan war. Drug Alcohol Depend. 2003;71:17–24.

    Article  PubMed  Google Scholar 

  40. Harvey E, Strathdee SA, Patrick DM, et al. A qualitative investigation into an HIV outbreak among injection drug users in Vancouver, British Columbia. AIDS Care. 1998;10:313–321.

    Article  CAS  PubMed  Google Scholar 

  41. Rhodes T, Lowndes C, Judd A, et al. Explosive spread and high prevalence of HIV infection among injecting drug users in togliatti city, Russia. AIDS. 2002;16:25–31.

    Article  Google Scholar 

  42. Bardach E. The Implementation Game: What Happens After a Bill Becomes Law. Cambridge MA: MIT Press; 1997.

    Google Scholar 

  43. Percy SL. Disability, Civil Rights, and Public Policy: The Politics of Implementation. Tuscaloosa, AL: University of alabama Press; 1989.

    Google Scholar 

  44. Galea S, Ahern J, Vlahov D. Contextual determinants of drug use risk behavior: a theoretic framework. J Urban Health. 2003;80:50–58.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steffanie A. Strathdee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strathdee, S.A., Fraga, W.D., Case, P. et al.Vivo para consumirla y la consumo para vivir” [“I live to inject and inject to live”]: High-Risk Injection Behaviors in Tijuana, Mexico. J Urban Health 82 (Suppl 4), iv58–iv73 (2005). https://doi.org/10.1093/jurban/jti108

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1093/jurban/jti108

Keywords

Navigation